ADC Therapeutics' IFRS loss in 9 months. In 2020, the loss was $190.361 million, up 2.3 times from $81.199 million in the previous year. The Group did not receive any revenue in the reporting period. A year earlier, it was $2.34 million.
ADC Therapeutics' IFRS loss in 9 months. In 2020, the loss was $190.361 million, up 2.3 times from $81.199 million in the previous year. The Group did not receive any revenue in the reporting period. A year earlier, it was $2.34 million. 
ir.adctherapeutics.com
English (US) 